5Dovern GV.Antimicrobial use and the emergence of antimicrobial resistance with streptococcus pneumoniae in the United States[J].Clin Infect Dis,2001,33(suppl 3):S187-192. 被引量：1
6Dolhoff A,Petersen U,Endermann R.In vitro activity of BAY 12-8039,a new 8-methoxyquinolo[J].Chemotherapy,1996,42:410-425. 被引量：1
7Andrews JM,Honeybourne D,Jevons G,et al.Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre optic bronchoscopy[J].J Antimicrob Chemother,1997,40:573-577. 被引量：1
8Soman A,Honeybourne D,Andrews J,et al.Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy[J].J Antimicrob Chemother,1999,44:835-838. 被引量：1
9Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the Management of Adults with Commnuity-acquired Pneumonia.Diagnosis,assessment of severity,antimicrobial therapy and prevention[J].Am J Respir Crit Care Med,2001,163:1730-1754. 被引量：1
